Complement-Activating Antibodies in Sera from Infected Individuals and Vaccinated Volunteers That Target Human Immunodeficiency Virus Type 1 to Complement Receptor Type 1 (CR1, CD35)
2010 ◽
Vol 91
(12)
◽
pp. 2965-2973
◽
2008 ◽
Vol 2008
◽
pp. 351-352
2009 ◽
Vol 00
(00)
◽
pp. 090923083856073-12
1993 ◽
Vol 129
(12)
◽
pp. 1620-1622
◽
2003 ◽
Vol 22
(4)
◽
pp. 281-286
◽